Monoclonal Antibodies
Scientists at University of Virginia, Department of Internal Medicine discuss research in monoclonal antibodies
Published in Health Risk Factor Week, January 23rd, 2007
Researchers detail in "Infliximab use in luminal Crohn's disease," new data in monoclonal antibodies. According to recent research from the United States, "Infliximab has been available in the United States and Europe for more than 6 years, and its use has revolutionized the care of patients who have CD. It is used effectively for both the induction and maintenance of remission in patients who have CD and is efficacious in patients who have steroid-dependent/refractory CD and those who have fistulizing CD."
"Clinical trials and practice have shown infliximab to be safe, effective, and generally well tolerated. The ACCENT I and ACCENT II trials defined the best dosing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis Immunology
New aspergillosis immunology research reported from University of British Columbia, Department of Radiology - Aspergillosis Therapy
New aspergillosis therapy findings from Veterans Administration Medical Center described - Bacterial Meningitis Epidemiology
Researchers' work from Academic Medical Center, Department of Neurology focuses on bacterial meningitis epidemiology - Bioterrorism
Researchers from National Institute of Allergy and Infectious Disease publish findings in bioterrorism - Bird Flu Epidemiology
Reports from National Cancer Institute, Department of Epidemiology highlight recent research in bird flu epidemiology - Botulism
Scientists at Center for Infections report research in botulism - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
